Skip to content

Capricor Therapeutics CAPR Business Segments — Other General And Administrative Expense

Similar metrics at other companies

Scholar Rock logo
SRRKSingle Reportable — Other General And Administrative Expense
$16.13M+80.4%
ArriVent BioPharma, Inc. logo
AVBPSingle Reportable — Other General And Administrative Expense
$2.31M+7.4%
Edgewise Therapeutics, Inc. logo
EWTXSingle Reportable — Other General Expense
$6.2M+38.8%
Axcelis Technologies logo
ACLSSingle Reportable — General And Administrative Expense
$26.76M+54.2%
Vertex, Inc. logo
VERXSingle Reportable — General And Administrative Expense
$54.34M+20.7%
Iovance Biotherapeutics, Inc. logo
IOVASingle Reportable — General And Administrative Expense
$18.7M-5.8%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherGeneralAndAdministrativeExpense.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's business segments — other general and administrative expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's business segments — other general and administrative expense?
Capricor Therapeutics (CAPR) reported business segments — other general and administrative expense of $4.12M in Q1 2026.
How has Capricor Therapeutics's business segments — other general and administrative expense changed year-over-year?
Capricor Therapeutics's business segments — other general and administrative expense increased by 199.3% year-over-year, from $1.38M to $4.12M.
What does business segments — other general and administrative expense mean?
This metric encompasses miscellaneous operating costs within the general and administrative category that are not classified as labor, share-based compensation, or depreciation. It typically includes professional fees, insurance, office overhead, and other corporate support costs. Tracking this provides insight into the efficiency of the company's back-office and administrative spending.